… We conclude that SARS-CoV-2 infection elicits robust neutralizing antibody … We show
that SARS-CoV-2 infection elicits robust neutralizing antibody titers in most individuals that last …

… Initial findings of low neutralising antibody titres and possible waning of titres over time may
have implications for sero-surveillance and disease control policy, although further evidence …

… titer could well be better protected against SARS-CoV-2. A recent letter in Journal of Infection
indicated that indeed neutralizing antibodies … in neutralizing antibodies after vaccination …

… symptomatic infection with a similar virus. Here we extend that work to show that neutralising
antibodies are also highly predictive of protection from SARS-CoV-2 variants of concern. …

… can predict neutralising antibody titres as antibody levels wane and viral variants emerge. …
antibody titres and immunity to SARS-CoV-2 is yet to be determined. Moreover, as antibodies …

… former SARS-CoV-2 infections who develop neutralising antibodies, whether their titres vary
… of participants with SARS-CoV-2 neutralising antibodies with titres >1:20 [9–26], 18 reported …

… to understand the longitudinal antibody responses against its first infection. Here we performed
a longitudinal study of antibody responses against SARS-CoV-2 in symptomatic patients. …

… antibodies to work together in a synergistic manner [25] (Fig. 1). Following an infection,
anti-SARS-CoV-2 S-specific IgM antibodies … IgM antibody titre initially rises during the first week of …

… SARS-CoV-2 anti-S antibody titres in individuals with no previous infection … titres in individuals
who have had a mild SARS-CoV-2 infection. Anti-S titres in those with previous SARS-CoV…

… , we observed higher SARS-CoV-2 antibody titers in the convalescent individuals aged ≥60
years, while in the vaccinated population higher SARS-CoV-2 antibody titers were seen in …